SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-006202
Filing Date
2024-04-30
Accepted
2024-04-30 07:56:02
Documents
17
Period of Report
2024-04-30
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pmn-20240430x8k.htm   iXBRL 8-K 40605
2 EX-99.1 pmn-20240430xex99d1.htm EX-99.1 16398
3 GRAPHIC pmn-20240430xex99d1001.jpg GRAPHIC 7073
  Complete submission text file 0001558370-24-006202.txt   237049

Data Files

Seq Description Document Type Size
4 EX-101.SCH pmn-20240430.xsd EX-101.SCH 4367
5 EX-101.DEF pmn-20240430_def.xml EX-101.DEF 2873
6 EX-101.LAB pmn-20240430_lab.xml EX-101.LAB 12908
7 EX-101.PRE pmn-20240430_pre.xml EX-101.PRE 12255
20 EXTRACTED XBRL INSTANCE DOCUMENT pmn-20240430x8k_htm.xml XML 5044
Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Filer) CIK: 0001374339 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41429 | Film No.: 24894078
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)